Reduced protein levels of both NGAL and MMP-9 have been detected in urine samples from bladder cancer patients with clinical relapse suggesting that reduced levels of these proteins may be used as indicators of tumor progression [26]. The gene discussed is MMP9; the disease is urinary bladder carcinoma.